-
1
-
-
0742324477
-
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity
-
Mailander V, Scheibenbogen C, Thiel E, Letsch A, Blau IW, Keilholz U. Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity. Leukemia 2004; 18: 165-166.
-
(2004)
Leukemia
, vol.18
, pp. 165-166
-
-
Mailander, V.1
Scheibenbogen, C.2
Thiel, E.3
Letsch, A.4
Blau, I.W.5
Keilholz, U.6
-
2
-
-
67049156789
-
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer
-
Feyerabend S, Stevanovic S, Gouttefangeas C, Wernet D, Hennenlotter J, Bedke J et al. Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer. Prostate 2009; 69: 917-927.
-
(2009)
Prostate
, vol.69
, pp. 917-927
-
-
Feyerabend, S.1
Stevanovic, S.2
Gouttefangeas, C.3
Wernet, D.4
Hennenlotter, J.5
Bedke, J.6
-
3
-
-
38949092908
-
RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses
-
Schmitt M, Schmitt A, Rojewski MT, Chen J, Giannopoulos K, Fei F et al. RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses. Blood 2008; 111: 1357-1365.
-
(2008)
Blood
, vol.111
, pp. 1357-1365
-
-
Schmitt, M.1
Schmitt, A.2
Rojewski, M.T.3
Chen, J.4
Giannopoulos, K.5
Fei, F.6
-
4
-
-
4644289323
-
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
-
Oka Y, Tsuboi A, Taguchi T, Osaki T, Kyo T, Nakajima H et al. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA 2004; 101: 13885-13890.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 13885-13890
-
-
Oka, Y.1
Tsuboi, A.2
Taguchi, T.3
Osaki, T.4
Kyo, T.5
Nakajima, H.6
-
5
-
-
38049188363
-
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
-
Rezvani K, Yong AS, Mielke S, Savani BN, Musse L, Superata J et al. Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies. Blood 2008; 111: 236-242.
-
(2008)
Blood
, vol.111
, pp. 236-242
-
-
Rezvani, K.1
Yong, A.S.2
Mielke, S.3
Savani, B.N.4
Musse, L.5
Superata, J.6
-
6
-
-
84864662070
-
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
-
Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 2012; 18: 1254-1261.
-
(2012)
Nat Med
, vol.18
, pp. 1254-1261
-
-
Walter, S.1
Weinschenk, T.2
Stenzl, A.3
Zdrojowy, R.4
Pluzanska, A.5
Szczylik, C.6
-
7
-
-
23644455476
-
Drug therapy for acute myeloid leukemia
-
Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005; 106: 1154-1163.
-
(2005)
Blood
, vol.106
, pp. 1154-1163
-
-
Tallman, M.S.1
Gilliland, D.G.2
Rowe, J.M.3
-
9
-
-
33751267902
-
Acute myeloid leukaemia
-
Estey E, Dohner H. Acute myeloid leukaemia. Lancet 2006; 368: 1894-1907.
-
(2006)
Lancet
, vol.368
, pp. 1894-1907
-
-
Estey, E.1
Dohner, H.2
-
11
-
-
0018764352
-
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts
-
Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068-1073.
-
(1979)
N Engl J Med
, vol.300
, pp. 1068-1073
-
-
Weiden, P.L.1
Flournoy, N.2
Thomas, E.D.3
Prentice, R.4
Fefer, A.5
Buckner, C.D.6
-
12
-
-
79952815781
-
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia
-
Bleakley M, Riddell SR. Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia. Immunol Cell Biol 2011; 89: 396-407.
-
(2011)
Immunol Cell Biol
, vol.89
, pp. 396-407
-
-
Bleakley, M.1
Riddell, S.R.2
-
13
-
-
0036129764
-
Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon
-
Brouwer RE, van der Heiden P, Schreuder GM, Mulder A, Datema G, Anholts JD et al. Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon. Hum Immunol 2002; 63: 200-210.
-
(2002)
Hum Immunol
, vol.63
, pp. 200-210
-
-
Brouwer, R.E.1
Van Der Heiden, P.2
Schreuder, G.M.3
Mulder, A.4
Datema, G.5
Anholts, J.D.6
-
14
-
-
0037356948
-
Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia
-
Vollmer M, Li L, Schmitt A, Greiner J, Reinhardt P, Ringhoffer M et al. Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia. Br J Haematol 2003; 120: 1000-1008.
-
(2003)
Br J Haematol
, vol.120
, pp. 1000-1008
-
-
Vollmer, M.1
Li, L.2
Schmitt, A.3
Greiner, J.4
Reinhardt, P.5
Ringhoffer, M.6
-
15
-
-
84867400336
-
Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia
-
Anguille S, Van Tendeloo VF, Berneman ZN. Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia. Leukemia 2012; 26: 2186-2196.
-
(2012)
Leukemia
, vol.26
, pp. 2186-2196
-
-
Anguille, S.1
Van Tendeloo, V.F.2
Berneman, Z.N.3
-
16
-
-
84899949862
-
Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues
-
Goswami M, Hensel N, Smith BD, Prince GT, Qin L, Levitsky HI et al. Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues. Leukemia 2014; 28: 1167-1170.
-
(2014)
Leukemia
, vol.28
, pp. 1167-1170
-
-
Goswami, M.1
Hensel, N.2
Smith, B.D.3
Prince, G.T.4
Qin, L.5
Levitsky, H.I.6
-
17
-
-
84884683734
-
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia
-
Cobbold M, De La Pena H, Norris A, Polefrone JM, Qian J, English AM et al. MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Sci Transl Med 2013; 5: 203ra125.
-
(2013)
Sci Transl Med
, vol.5
, pp. 203ra125
-
-
Cobbold, M.1
De La Pena, H.2
Norris, A.3
Polefrone, J.M.4
Qian, J.5
English, A.M.6
-
18
-
-
84857401848
-
Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: Lessons from early clinical trials
-
Van Driessche A, Berneman ZN, Van Tendeloo VF. Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials. Oncologist 2012; 17: 250-259.
-
(2012)
Oncologist
, vol.17
, pp. 250-259
-
-
Van Driessche, A.1
Berneman, Z.N.2
Van Tendeloo, V.F.3
-
19
-
-
58249088449
-
Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-speci fic CTL epitope
-
Li Z, Oka Y, Tsuboi A, Fujiki F, Harada Y, Nakajima H et al. Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-speci fic CTL epitope. Microbiol Immunol 2008; 52: 551-558.
-
(2008)
Microbiol Immunol
, vol.52
, pp. 551-558
-
-
Li, Z.1
Oka, Y.2
Tsuboi, A.3
Fujiki, F.4
Harada, Y.5
Nakajima, H.6
-
20
-
-
78649304608
-
Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model
-
Ma Q, Wang C, Jones D, Quintanilla KE, Li D, Wang Y et al. Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model. Cytotherapy 2010; 12: 1056-1062.
-
(2010)
Cytotherapy
, vol.12
, pp. 1056-1062
-
-
Ma, Q.1
Wang, C.2
Jones, D.3
Quintanilla, K.E.4
Li, D.5
Wang, Y.6
-
21
-
-
77952952932
-
High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma
-
Greiner J, Schmitt A, Giannopoulos K, Rojewski MT, Gotz M, Funk I et al. High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma. Haematologica 2010; 95: 1191-1197.
-
(2010)
Haematologica
, vol.95
, pp. 1191-1197
-
-
Greiner, J.1
Schmitt, A.2
Giannopoulos, K.3
Rojewski, M.T.4
Gotz, M.5
Funk, I.6
-
22
-
-
77956384935
-
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
-
Van Tendeloo VF, Van de Velde A, Van Driessche A, Cools N, Anguille S, Ladell K et al. Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci USA 2010; 107: 13824-13829.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 13824-13829
-
-
Van Tendeloo, V.F.1
Van De Velde, A.2
Van Driessche, A.3
Cools, N.4
Anguille, S.5
Ladell, K.6
-
23
-
-
29844437061
-
Vaccination with the PR1 leukemia-associated antigen can induce complete remission in patients with myeloid leukemia
-
Qazilbash MH, Rios R, Lu SJ, Giralt S. Vaccination with the PR1 leukemia-associated antigen can induce complete remission in patients with myeloid leukemia. Blood 2004; 104: 77A.
-
(2004)
Blood
, vol.104
, pp. 77A
-
-
Qazilbash, M.H.1
Rios, R.2
Lu, S.J.3
Giralt, S.4
-
24
-
-
51549118696
-
PR1 vaccine elicited immunological response after hematopoietic stem cell transplantation is associated with better clinical response and event-free survival
-
Qazilbash MH, Thall PF, Wang X, Rios RL, Lu S. PR1 vaccine elicited immunological response after hematopoietic stem cell transplantation is associated with better clinical response and event-free survival. Blood 2007; 110: 178A.
-
(2007)
Blood
, vol.110
, pp. 178A
-
-
Qazilbash, M.H.1
Thall, P.F.2
Wang, X.3
Rios, R.L.4
Lu, S.5
-
25
-
-
67649664091
-
HLA ligand profiles of primary renal cell carcinoma maintained in metastases
-
Stickel JS, Weinzierl AO, Hillen N, Drews O, Schuler MM, Hennenlotter J et al. HLA ligand profiles of primary renal cell carcinoma maintained in metastases. Cancer Immunol Immunother 2009; 58: 1407-1417.
-
(2009)
Cancer Immunol Immunother
, vol.58
, pp. 1407-1417
-
-
Stickel, J.S.1
Weinzierl, A.O.2
Hillen, N.3
Drews, O.4
Schuler, M.M.5
Hennenlotter, J.6
-
26
-
-
33846534321
-
Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface
-
Weinzierl AO, Lemmel C, Schoor O, Muller M, Kruger T, Wernet D et al. Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics 2007; 6: 102-113.
-
(2007)
Mol Cell Proteomics
, vol.6
, pp. 102-113
-
-
Weinzierl, A.O.1
Lemmel, C.2
Schoor, O.3
Muller, M.4
Kruger, T.5
Wernet, D.6
-
27
-
-
84883455063
-
Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer
-
Neumann A, Horzer H, Hillen N, Klingel K, Schmid-Horch B, Buhring HJ et al. Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer. Cancer Immunol Immunother 2013; 62: 1485-1497.
-
(2013)
Cancer Immunol Immunother
, vol.62
, pp. 1485-1497
-
-
Neumann, A.1
Horzer, H.2
Hillen, N.3
Klingel, K.4
Schmid-Horch, B.5
Buhring, H.J.6
-
28
-
-
84883718340
-
Natural HLA class I ligands from glioblastoma: Extending the options for immunotherapy
-
Neidert MC, Schoor O, Trautwein C, Trautwein N, Christ L, Melms A et al. Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy. J Neurooncol 2013; 111: 285-294.
-
(2013)
J Neurooncol
, vol.111
, pp. 285-294
-
-
Neidert, M.C.1
Schoor, O.2
Trautwein, C.3
Trautwein, N.4
Christ, L.5
Melms, A.6
-
29
-
-
0025855156
-
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
-
Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991; 351: 290-296.
-
(1991)
Nature
, vol.351
, pp. 290-296
-
-
Falk, K.1
Rotzschke, O.2
Stevanovic, S.3
Jung, G.4
Rammensee, H.G.5
-
30
-
-
84879310264
-
Biochemical large-scale identification of MHC class I ligands
-
Kowalewski DJ, Stevanovic S. Biochemical large-scale identification of MHC class I ligands. Methods Mol Biol 2013; 960: 145-157.
-
(2013)
Methods Mol Biol
, vol.960
, pp. 145-157
-
-
Kowalewski, D.J.1
Stevanovic, S.2
-
31
-
-
35748972060
-
Semi-supervised learning for peptide identification from shotgun proteomics datasets
-
Kall L, Canterbury JD, Weston J, Noble WS, MacCoss MJ. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods 2007; 4: 923-925.
-
(2007)
Nat Methods
, vol.4
, pp. 923-925
-
-
Kall, L.1
Canterbury, J.D.2
Weston, J.3
Noble, W.S.4
MacCoss, M.J.5
-
32
-
-
84875888331
-
Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons
-
Sturm T, Leinders-Zufall T, Macek B, Walzer M, Jung S, Pommerl B et al. Mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons. Nat Commun 2013; 4: 1616.
-
(2013)
Nat Commun
, vol.4
, pp. 1616
-
-
Sturm, T.1
Leinders-Zufall, T.2
Macek, B.3
Walzer, M.4
Jung, S.5
Pommerl, B.6
-
33
-
-
84860224443
-
Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients
-
Widenmeyer M, Griesemann H, Stevanovic S, Feyerabend S, Klein R, Attig S et al. Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients. Int J Cancer 2012; 131: 140-149.
-
(2012)
Int J Cancer
, vol.131
, pp. 140-149
-
-
Widenmeyer, M.1
Griesemann, H.2
Stevanovic, S.3
Feyerabend, S.4
Klein, R.5
Attig, S.6
-
34
-
-
37349077911
-
The CIMT-monitoring panel: A two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays
-
Britten CM, Gouttefangeas C, Welters MJ, Pawelec G, Koch S, Ottensmeier C et al. The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother 2008; 57: 289-302.
-
(2008)
Cancer Immunol Immunother
, vol.57
, pp. 289-302
-
-
Britten, C.M.1
Gouttefangeas, C.2
Welters, M.J.3
Pawelec, G.4
Koch, S.5
Ottensmeier, C.6
-
35
-
-
84255197842
-
Cancer immunotherapy comes of age
-
Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature 2011; 480: 480-489.
-
(2011)
Nature
, vol.480
, pp. 480-489
-
-
Mellman, I.1
Coukos, G.2
Dranoff, G.3
-
36
-
-
0035144395
-
HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse
-
Wetzler M, Baer MR, Stewart SJ, Donohue K, Ford L, Stewart CC et al. HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse. Leukemia 2001; 15: 128-133.
-
(2001)
Leukemia
, vol.15
, pp. 128-133
-
-
Wetzler, M.1
Baer, M.R.2
Stewart, S.J.3
Donohue, K.4
Ford, L.5
Stewart, C.C.6
-
37
-
-
84878372012
-
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
-
Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059-2074.
-
(2013)
N Engl J Med
, vol.368
, pp. 2059-2074
-
-
Cancer Genome Atlas Research Network1
-
38
-
-
84863393263
-
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
-
Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012; 366: 1079-1089.
-
(2012)
N Engl J Med
, vol.366
, pp. 1079-1089
-
-
Patel, J.P.1
Gonen, M.2
Figueroa, M.E.3
Fernandez, H.4
Sun, Z.5
Racevskis, J.6
-
39
-
-
69049089548
-
The prioritization of cancer antigens: A national cancer institute pilot project for the acceleration of translational research
-
Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 2009; 15: 5323-5337.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5323-5337
-
-
Cheever, M.A.1
Allison, J.P.2
Ferris, A.S.3
Finn, O.J.4
Hastings, B.M.5
Hecht, T.T.6
-
40
-
-
84880160266
-
An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide
-
Hardwick N, Buchan S, Ingram W, Khan G, Vittes G, Rice J et al. An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide. Cancer Immun 2013; 13: 16.
-
(2013)
Cancer Immun
, vol.13
, pp. 16
-
-
Hardwick, N.1
Buchan, S.2
Ingram, W.3
Khan, G.4
Vittes, G.5
Rice, J.6
-
41
-
-
33947596047
-
A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells
-
Graf C, Heidel F, Tenzer S, Radsak MP, Solem FK, Britten CM et al. A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells. Blood 2007; 109: 2985-2988.
-
(2007)
Blood
, vol.109
, pp. 2985-2988
-
-
Graf, C.1
Heidel, F.2
Tenzer, S.3
Radsak, M.P.4
Solem, F.K.5
Britten, C.M.6
-
42
-
-
68049137903
-
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation
-
Beatty GL, Smith JS, Reshef R, Patel KP, Colligon TA, Vance BA et al. Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation. Clin Cancer Res 2009; 15: 4944-4953.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 4944-4953
-
-
Beatty, G.L.1
Smith, J.S.2
Reshef, R.3
Patel, K.P.4
Colligon, T.A.5
Vance, B.A.6
-
43
-
-
59449103841
-
Aurora-A kinase: A novel target of cellular immunotherapy for leukemia
-
Ochi T, Fujiwara H, Suemori K, Azuma T, Yakushijin Y, Hato T et al. Aurora-A kinase: a novel target of cellular immunotherapy for leukemia. Blood 2009; 113: 66-74.
-
(2009)
Blood
, vol.113
, pp. 66-74
-
-
Ochi, T.1
Fujiwara, H.2
Suemori, K.3
Azuma, T.4
Yakushijin, Y.5
Hato, T.6
-
44
-
-
84862578742
-
Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen
-
Ochsenreither S, Majeti R, Schmitt T, Stirewalt D, Keilholz U, Loeb KR et al. Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen. Blood 2012; 119: 5492-5501.
-
(2012)
Blood
, vol.119
, pp. 5492-5501
-
-
Ochsenreither, S.1
Majeti, R.2
Schmitt, T.3
Stirewalt, D.4
Keilholz, U.5
Loeb, K.R.6
-
45
-
-
84865180738
-
Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia
-
Greiner J, Ono Y, Hofmann S, Schmitt A, Mehring E, Gotz M et al. Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia. Blood 2012; 120: 1282-1289.
-
(2012)
Blood
, vol.120
, pp. 1282-1289
-
-
Greiner, J.1
Ono, Y.2
Hofmann, S.3
Schmitt, A.4
Mehring, E.5
Gotz, M.6
-
46
-
-
0032482474
-
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
-
Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998; 393: 480-483.
-
(1998)
Nature
, vol.393
, pp. 480-483
-
-
Schoenberger, S.P.1
Toes, R.E.2
Van Der Voort, E.I.3
Offringa, R.4
Melief, C.J.5
-
47
-
-
4644271443
-
CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection
-
Sun JC, Williams MA, Bevan MJ. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 2004; 5: 927-933.
-
(2004)
Nat Immunol
, vol.5
, pp. 927-933
-
-
Sun, J.C.1
Williams, M.A.2
Bevan, M.J.3
-
48
-
-
0037456367
-
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
-
Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003; 421: 852-856.
-
(2003)
Nature
, vol.421
, pp. 852-856
-
-
Janssen, E.M.1
Lemmens, E.E.2
Wolfe, T.3
Christen, U.4
Von Herrath, M.G.5
Schoenberger, S.P.6
-
49
-
-
0033587720
-
CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma
-
Mumberg D, Monach PA, Wanderling S, Philip M, Toledano AY, Schreiber RD et al. CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma. Proc Natl Acad Sci USA 1999; 96: 8633-8638.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 8633-8638
-
-
Mumberg, D.1
Monach, P.A.2
Wanderling, S.3
Philip, M.4
Toledano, A.Y.5
Schreiber, R.D.6
-
50
-
-
0033662405
-
CD4(+) T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells
-
Qin ZH, Blankenstein T. CD4(+) T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 2000; 12: 677-686.
-
(2000)
Immunity
, vol.12
, pp. 677-686
-
-
Qin, Z.H.1
Blankenstein, T.2
-
51
-
-
44449137591
-
TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis
-
Muller-Hermelink N, Braumuller H, Pichler B, Wieder T, Mailhammer R, Schaak K et al. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 2008; 13: 507-518.
-
(2008)
Cancer Cell
, vol.13
, pp. 507-518
-
-
Muller-Hermelink, N.1
Braumuller, H.2
Pichler, B.3
Wieder, T.4
Mailhammer, R.5
Schaak, K.6
-
52
-
-
34249990107
-
CD4 cells can be more efficient at tumor rejection than CD8 cells
-
Perez-Diez A, Joncker NT, Choi K, Chan WF, Anderson CC, Lantz O et al. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 2007; 109: 5346-5354.
-
(2007)
Blood
, vol.109
, pp. 5346-5354
-
-
Perez-Diez, A.1
Joncker, N.T.2
Choi, K.3
Chan, W.F.4
Anderson, C.C.5
Lantz, O.6
-
53
-
-
84882989956
-
Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor
-
Tomita Y, Yuno A, Tsukamoto H, Senju S, Kuroda Y, Hirayama M et al. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor. Clin Cancer Res 2013; 19: 4508-4520.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 4508-4520
-
-
Tomita, Y.1
Yuno, A.2
Tsukamoto, H.3
Senju, S.4
Kuroda, Y.5
Hirayama, M.6
-
54
-
-
84882999952
-
'License to kill' reflects joint action of CD4 and CD8 T cells
-
Melief CJ. 'License to kill' reflects joint action of CD4 and CD8 T cells. Clin Cancer Res 2013; 19: 4295-4296.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 4295-4296
-
-
Melief, C.J.1
|